Liver Supplement May Enhance Cancer Immunotherapy Effectiveness
Originally Published 2 months ago — by Science Daily
Scientists at the Salk Institute found that bile acids, especially ursodeoxycholic acid (UDCA), influence immune cell function in the liver and could enhance immunotherapy effectiveness against liver cancer, with UDCA supplements already approved for other liver conditions offering a promising therapeutic avenue.